Skip to content

Drug interactions

Deflazacort + Netupitant / palonosetron

Severity: Moderate

Deflazacort and Netupitant / palonosetron: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Netupitant is a moderate CYP3A4 inhibitor and may increase exposure to deflazacort's active metabolite. Corticosteroid effects may be enhanced, although exposure is usually short-term with antiemetic use.

What this interaction means in plain words

Deflazacort and Netupitant / palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Netupitant inhibits CYP3A4, reducing clearance of deflazacort's active metabolite.

What to do

Reduce deflazacort to one-third of the usual dose when used with moderate CYP3A4 inhibitors, per labeling. Monitor for corticosteroid adverse effects.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deflazacort and Netupitant / palonosetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deflazacort with Netupitant / palonosetron?

MediHelp rates the interaction as moderate. Deflazacort and Netupitant / palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Netupitant is a moderate CYP3A4 inhibitor and may increase exposure to deflazacort's active metabolite. Corticosteroid effects may be enhanced, although exposure is usually short-term with antiemetic use.

How serious is the interaction between Deflazacort and Netupitant / palonosetron?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce deflazacort to one-third of the usual dose when used with moderate CYP3A4 inhibitors, per labeling. Monitor for corticosteroid adverse effects.

What other medicines interact with Deflazacort?

MediHelp also lists interactions of Deflazacort with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Deflazacort page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in